Cue Biopharma
Ownership
Ownership Structure
Who owns Cue Biopharma (CUE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 94.2% of the shares are freely tradable; institutional investors hold 14.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Bleichroeder LP | 3.13 | 6,819,164 | +0.0 | 03/31/2026 |
| Polygon Management Ltd | 1.29 | 93,819 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 1.13 | 2,457,452 | +0.0 | 03/31/2026 |
| Lion Point Capital, LP | 0.73 | 52,928 | -27.9 | 06/30/2026 |
| Squadron Capital Management LLC | 0.69 | 50,000 | +0.0 | 06/30/2026 |
| Diadema Partners LP | 0.67 | 48,369 | +999.5 | 06/30/2026 |
| Geode Capital Management, LLC | 0.49 | 1,064,690 | +32.5 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.25 | 543,585 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.54 | 111,867 | +0.0 | 08/31/2026 |
| Fidelity Extended Market Index | 0.27 | 19,842 | -5.8 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Lin Shao-Lee | Chief Executive Officer | 705,995 | 22,168,243 $ | Aug 13, 2026 | direct |
| Ray Sumita | Chief Legal Compliance Officer | 118,545 | 3,722,313 $ | Aug 13, 2026 | direct |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | 48,961 | 1,537,375 $ | Aug 13, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Sell | 3 | 31.13 | 93 |
| Aug 13, 2026 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Sell | 4,106 | 30.35 | 124,617 |
| Aug 13, 2026 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Sell | 1,519 | 29.37 | 44,613 |
| Aug 13, 2026 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Other | 13,647 | 0.00 | – |
| Aug 13, 2026 | Ray Sumita | Chief Legal Compliance Officer | Sell | 4 | 31.13 | 125 |
| Aug 13, 2026 | Ray Sumita | Chief Legal Compliance Officer | Sell | 6,442 | 30.35 | 195,515 |
| Aug 13, 2026 | Ray Sumita | Chief Legal Compliance Officer | Sell | 2,383 | 29.37 | 69,989 |
| Aug 13, 2026 | Ray Sumita | Chief Legal Compliance Officer | Other | 18,196 | 0.00 | – |
| Aug 13, 2026 | Lin Shao-Lee | Chief Executive Officer | Sell | 10,460 | 29.48 | 308,361 |
| Aug 13, 2026 | Lin Shao-Lee | Chief Executive Officer | Sell | 2,375 | 28.11 | 66,761 |
| Aug 13, 2026 | Lin Shao-Lee | Chief Executive Officer | Sell | 5,423 | 27.19 | 147,451 |
| Aug 12, 2026 | Lin Shao-Lee | Chief Executive Officer | Sell | 5,775 | 27.75 | 160,256 |
| Aug 12, 2026 | Lin Shao-Lee | Chief Executive Officer | Sell | 34,225 | 26.99 | 923,733 |
| Aug 12, 2026 | Lin Shao-Lee | Chief Executive Officer | Other | 109,179 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.